Hematologist Usama Gergis, MD, MBA, Joins Sidney Kimmel Cancer Center
Usama Gergis, MD, MBA
The Sidney Kimmel Cancer Center–Jefferson Health (Sidney Kimmel) welcomes Usama Gergis, MD, MBA, as Director of the Bone Marrow Transplant and Immune Cellular Therapy Program and Professor in the Department of Medical Oncology, Division of Hematological Malignancies.
Dr. Gergis joins Sidney Kimmel from Weill Cornell Medical College in New York, where he spent the past 12 years. His areas of expertise include high-risk myeloid malignancies, graft-vs-host disease, and hematopoietic stem cell transplantation for patients who lack matched donors (alternative donor transplantation).
While at Weill Cornell, Dr. Gergis helped to expand the use of umbilical cord transplant and established an immune cellular therapy program. Additionally, he established and led one of the largest international oncology programs in the nation.
Dr. Gergis received his medical degree from Cairo University School of Medicine. After completing an internal medicine residency and a hematology/oncology fellowship at the Brooklyn Hospital of Weill Cornell, he completed a bone marrow transplant fellowship at the Moffitt Cancer Center in Tampa, Florida. In 2017, he obtained a master’s in business administration from the Johnson School of Management of Cornell University.
Dr. Gergis has authored and coauthored more than 75 peer-reviewed original articles and chapter books and has given presentations at major academic centers and international conferences. He is a member of many prestigious academic societies and is an active reviewer of a score of leading peer reviewed journals.